Cyclosporine A loaded SLNs: Evaluation of cellular uptake and corneal cytotoxicity

被引:137
作者
Gokce, Evren H. [1 ]
Sandri, Giuseppina [2 ]
Bonferoni, M. Cristina [2 ]
Rossi, Silvia [2 ]
Ferrari, Franca [2 ]
Guneri, Tamer [1 ]
Caramella, Carla [2 ]
机构
[1] Univ Ege, Fac Pharm, Dept Pharmaceut Technol, TR-35100 Izmir, Turkey
[2] Univ Pavia, Sch Pharm, Dept Pharmaceut Chem, I-27100 Pavia, Italy
关键词
Solid lipid nanoparticles; Cyclosporine A; ophthalmic; Cytotoxicity; Penetration; Cellular uptake;
D O I
10.1016/j.ijpharm.2008.07.028
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Cyclosporine A (CsA) loaded solid lipid nanoparticles (SLNs) for topical ophthalmic applications were prepared by high shear homogenization and ultrasound method using Compritol 888 ATO, Poloxamer 188 and Tween 80, to investigate the cellular uptake of rabbit corneal epithelial cells (RCE) and to evaluate the cytotoxicity. The size of the optimized formulation was 225.9 +/- 5.5 nm with a polydispersity index of 0.253 +/- 0.05. The zeta potential and entrapment efficiency was detected as -16.9 +/- 0.7 mV and 95.6%, respectively. The CsA release was found to be enzyme (lipase/co-lipase complex) dependent. SLNs were sterilized at 110 and 121 degrees C. The cytotoxicity was evaluated in vitro by means of RCE cells and was higher at 121 degrees C sterilization temperature, probably due to a supposed leakage of Tween 80 following lipid recrystallization. The permeation and penetration of CsA across/into the corneal cells were evaluated using in vitro and ex vivo experiments. The cellular uptake was investigated by replacing CsA with the fluorescent dye Rhodamine B. The penetration enhancement properties were supported by confocal laser scanning microscopy analysis. The internalization of SLNs in cornea and in RCE cell lines was confirmed, pointing out the possibility of CsA targeting to the cornea. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:76 / 86
页数:11
相关论文
共 44 条
  • [1] Peptide-loaded solid lipid nanoparticles (SLN): Influence of production parameters
    Almeida, AJ
    Runge, S
    Muller, RH
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1997, 149 (02) : 255 - 265
  • [2] BABICH H, 1990, ATLA-ALTERN LAB ANIM, V18, P129
  • [3] Ophthalmic drug design based on the metabolic activity of the eye: Soft drugs and chemical delivery systems
    Bodor, N
    Buchwald, P
    [J]. AAPS JOURNAL, 2005, 7 (04) : E820 - E833
  • [4] CRYSTALLIZATION MECHANISMS IN SOLUTION
    BOISTELLE, R
    ASTIER, JP
    [J]. JOURNAL OF CRYSTAL GROWTH, 1988, 90 (1-3) : 14 - 30
  • [5] Development of cultured rabbit corneal epithelium for drug permeation studies: A comparison with excised rabbit cornea
    Burgalassi, S
    Monti, D
    Brignoccoli, A
    Fabiani, O
    Lenzi, C
    Pirone, A
    Chetoni, P
    [J]. JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 20 (06) : 518 - 532
  • [6] Cytotoxicity of potential ocular permeation enhancers evaluated on rabbit and human corneal epithelial cell lines
    Burgalassi, S
    Chetoni, P
    Monti, D
    Saettone, MF
    [J]. TOXICOLOGY LETTERS, 2001, 122 (01) : 1 - 8
  • [7] Solid lipid nanoparticles (SLN) as ocular delivery system for tobramycin
    Cavalli, R
    Gasco, MR
    Chetoni, P
    Burgalassi, S
    Saettone, MF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2002, 238 (1-2) : 241 - 245
  • [8] PREPARATION AND EVALUATION IN-VITRO OF COLLOIDAL LIPOSPHERES CONTAINING PILOCARPINE AS ION-PAIR
    CAVALLI, R
    MOREL, S
    GASCO, MR
    CHETONI, P
    SAETTONE, MF
    [J]. INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1995, 117 (02) : 243 - 246
  • [9] The effect of a PEG versus a chitosan coating on the interaction of drug colloidal carriers with the ocular mucosa
    De Campos, AM
    Sánchez, A
    Gref, R
    Calvo, P
    Alonso, MJ
    [J]. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2003, 20 (01) : 73 - 81
  • [10] Recent developments in ophthalmic drug delivery
    Ding, SL
    [J]. PHARMACEUTICAL SCIENCE & TECHNOLOGY TODAY, 1998, 1 (08): : 328 - 335